- Home
- FLR vs STVN Comparison
FLR vs STVN Comparison
Compare FLR & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLR
- STVN
- Stock Information
- Founded
- FLR 1912
- STVN 1949
- Country
- FLR United States
- STVN Italy
- Employees
- FLR N/A
- STVN N/A
- Industry
- FLR Military/Government/Technical
- STVN Containers/Packaging
- Sector
- FLR Industrials
- STVN Consumer Discretionary
- Exchange
- FLR Nasdaq
- STVN Nasdaq
- Market Cap
- FLR 6.7B
- STVN 6.2B
- IPO Year
- FLR N/A
- STVN 2021
- Fundamental
- Price
- FLR $41.35
- STVN $26.05
- Analyst Decision
- FLR Buy
- STVN Buy
- Analyst Count
- FLR 7
- STVN 4
- Target Price
- FLR $50.57
- STVN $25.13
- AVG Volume (30 Days)
- FLR 3.8M
- STVN 370.0K
- Earning Date
- FLR 11-07-2025
- STVN 11-04-2025
- Dividend Yield
- FLR N/A
- STVN 0.24%
- EPS Growth
- FLR 970.51
- STVN 6.78
- EPS
- FLR 24.07
- STVN 0.57
- Revenue
- FLR $16,313,000,000.00
- STVN $1,344,798,591.00
- Revenue This Year
- FLR $3.29
- STVN $8.24
- Revenue Next Year
- FLR $4.33
- STVN $10.38
- P/E Ratio
- FLR $1.72
- STVN $44.98
- Revenue Growth
- FLR 3.61
- STVN 5.28
- 52 Week Low
- FLR $29.20
- STVN $17.12
- 52 Week High
- FLR $60.10
- STVN $28.00
- Technical
- Relative Strength Index (RSI)
- FLR 42.17
- STVN 61.90
- Support Level
- FLR $40.24
- STVN $22.46
- Resistance Level
- FLR $43.94
- STVN $25.88
- Average True Range (ATR)
- FLR 1.30
- STVN 1.25
- MACD
- FLR 0.30
- STVN 0.48
- Stochastic Oscillator
- FLR 39.49
- STVN 79.20
About FLR Fluor Corporation
Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services.It serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.
About STVN Stevanato Group S.p.A.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.